Correlating efficacy and desensitization with GluK2 ligand-binding domain movements

Area of Science:

• Neuroscience
• Molecular Biology
• Structural Biology

Background:

• Ionotropic glutamate receptors, including AMPA and kainate types, are crucial for synaptic transmission.
• Their function is modulated by ligand affinity, efficacy, and desensitization rates.
• Structural studies of the ligand-binding domain (LBD) provide key insights into receptor gating.

Purpose of the Study:

• To investigate the relationship between LBD dimer interface contacts, receptor efficacy, and desensitization in the kainate-selective GluK2 subunit.
• To understand the structural basis for the observed effects of specific mutations on GluK2 receptor function.

Main Methods:

• Site-directed mutagenesis of key residues (K531 and R775) in the GluK2 LBD dimer interface.
• Functional characterization of mutant receptors to assess ligand efficacy and desensitization.
• X-ray crystallography to determine the structures of mutant LBDs and analyze conformational changes and anion binding.

Main Results:

• Mutations at K531 and R775 altered desensitization rates and, in the case of K531A, switched the relative efficacies of glutamate and kainate.
• Crystal structures revealed conformational changes, including new dimer contacts and altered ligand-binding cleft dynamics, correlating with functional phenotypes.
• Mutations disrupted anion binding, particularly chloride at the dimer interface, suggesting its role in receptor stability.

Conclusions:

• The charge balance within the GluK2 LBD dimer interface is critical for maintaining the instability required for rapid and complete desensitization.
• Structural insights explain how mutations affecting dimer contacts and anion binding influence receptor gating properties.
• This study elucidates mechanisms underlying ionotropic glutamate receptor desensitization and efficacy.